Assessment of Sexual Function in Breast Cancer Survivors

Key points
- Inquiring about topics such as menopausal status, birth control, vaginal dryness, and dyspareunia shows the breast cancer patient that her healthcare team members consider topics influencing sexuality to be important.
- There are a number of predisposing factors for sexual dysfunction after breast cancer diagnosis and treatment, including preexisting sexual problems and normal age-related changes in sexual function.
- Basson (2006) has recently reviewed sexual desire and arousal disorders in women and offered guidelines for assessment and diagnosis of sexual dysfunction.
- In addition, each partner's mood should be assessed.
Inquiring about topics such as menopausal status, birth control, vaginal dryness, and dyspareunia shows the breast cancer patient that her healthcare team members consider topics influencing sexuality to be important. This may increase the likelihood that the patient will tell a member or members of her healthcare team about any sexual problems that arise during active treatment and subsequent follow-up.
There are a number of predisposing factors for sexual dysfunction after breast cancer diagnosis and treatment, including preexisting sexual problems and normal age-related changes in sexual function.
Basson (2006) has recently reviewed sexual desire and arousal disorders in women and offered guidelines for assessment and diagnosis of sexual dysfunction. In addition to information obtained from interviewing the couple, information obtained from each partner during separate interviews should include the partner's assessment of the problem and information about sexual response with self-stimulation; past sexual experiences; developmental history; past or current sexual, emotional, or physical abuse; and physical health (especially conditions that can lead to debility and fatigue, impaired mobility, or difficulties with self-image).
In addition, each partner's mood should be assessed. Basson also discusses the components of the physical examination that could be important in diagnosing and treating sexual dysfunction in a woman: examination of the external genitalia, examination of the introitus, full bimanual examination, and nongenital physical examination.
Such a detailed history and physical examination may be difficult for a medical, surgical, or radiation oncologist to accomplish during an office or clinic visit-physicians may not be comfortable with the topic of sexual dysfunction and may have limited knowledge of sexual desire and arousal disorders in women, and both time and expertise are required to accurately diagnose and effectively treat such disorders.
Therefore, at M. D. Anderson, a multidisciplinary approach is used to adequately identify and treat sexual dysfunction in breast cancer survivors. We rely on the expertise of our colleagues in the Departments of Gynecologic Oncology and Psychiatry to help us, our patients, and their partners deal with this sensitive but important survivorship issue.
Karin M. E. Hahn
The University of Texas, Department of Breast Medical Oncology
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNonrecommended screenings for prostate, breast cancer in older individuals
An estimated 15.7 percent of individuals 65 or older may have received nonrecommended screenings for prostate and breast cancers because they had limited life expectancies of less than 10 years, according to an article…
22 January 2016
GuideNew method for better treatment of breast cancer
A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling. The…
31 December 2015
NewsT cells that recognize HER2 teceptor may prevent HER2+ breast cancer recurrence
Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient's immune system - a weakness that in principle could be corrected with a…




